LCY Lui, RTT Chan, CCH Kwok, WM Wong, CC Yau, GKH Au, CL Lai
Hong Kong J Radiol 2004;7:72-5
Objective: To analyse the incidence of hepatitis B reactivation following treatment with irinotecan-based combined chemotherapy and the outcomes of patients with hepatitis B reactivation.
Patients and Methods: A prospective phase II study investigating the response to irinotecan, leucovorin, and 5-fluorouracil